Skip to content
Screener

OrthoPediatrics KIDS Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$1.06M+79.7%
Globus Medical logo
Globus MedicalGMED
$44.37M+66.8%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$2.23M+24.5%
Enovis logo
EnovisENOV
$28.18M0.0%
Bioventus logo
BioventusBVS
$2.61M-9.9%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$70.5M+15.4%
Gross profit$52.4M+19.0%
Operating income-$4.1M+61.8%
Net income-$7.2M-0.7%
EPS (diluted)-$0.300.0%

Balance sheet

See full
Cash & equivalents$19.1M-59.1%
Total debt$4.6M+234%
Total equity$343.6M-3.3%
Total assets$511.4M+1.5%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$4.0M+17.4%
Free cash flow-$3.1M+77.6%

Valuation

See full
Market cap$607.84M+28.9%
Enterprise value$593.34M+39.2%
P/S2.4×+0.3×

Profitability

See full
Gross margin73.7%+2.1pp
Operating margin-11.9%-3.2pp
Net margin-15.7%-2.3pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.4%-0.1pp
Debt / equity0.0×
Current ratio4.8×-1.9×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The source filing: OrthoPediatrics’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 1:56 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001425450-26-000070
Line itemJune 30, 2026December 31, 2025
Cash$17,001$19,556
Restricted cash2,0542,064
Short-term investments28,87841,295
Accounts receivable - trade, net of allowances of $1,680 and $1,501, respectively60,95153,838
Inventories, net137,567133,790
Prepaid expenses and other current assets6,0575,876
Total current assets252,508256,419
Property and equipment, net48,55249,555

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is OrthoPediatrics's allowance for doubtful accounts receivable (current)?
OrthoPediatrics (KIDS) reported allowance for doubtful accounts receivable (current) of $1.68M in Q2 2026.
How has OrthoPediatrics's allowance for doubtful accounts receivable (current) changed year-over-year?
OrthoPediatrics's allowance for doubtful accounts receivable (current) increased by 19.1% year-over-year, from $1.41M to $1.68M.
What is the long-term trend for OrthoPediatrics's allowance for doubtful accounts receivable (current)?
Over 5 years (2020 to 2025), OrthoPediatrics's allowance for doubtful accounts receivable (current) has grown at a 28.2% compound annual growth rate (CAGR), from $433K to $1.5M.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about OrthoPediatrics's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude